1156
H. Eshghi et al. / Chinese Chemical Letters 23 (2012) 1153–1156
[14] H. Eshghi, M. Bakavoli, H. Moradi, Chin. Chem. Lett. 19 (2008) 1423.
[15] H. Eshghi, G.H. Zohuri, S. Damavandi, M. Vakili, Chin. Chem. Lett. 21 (2010) 1423.
[16] P. Salehi, M.M. Khodaei, M.A. Zolfigol, S. Zeinoldini, Synth. Commun. 33 (2003) 1367.
[17] K.P. Boroujeni, Chin. Chem. Lett. 21 (2010) 1395.
[18] H. Eshghi, J. Chin. Chem. Soc. 53 (2006) 987.
[19] C. Wang, L.J. Zhang, Z. Zhang, Z.J. Quan, Chin. Chem. Lett. 23 (2012) 423.
[20] F. Shirini, M.A. Zolfigol, P. Salehi, M. Abedini, Curr. Org. Chem. 12 (2008) 183.
[21] H. Eshghi, M. Rahimizadeh, S. Saberi, Catal. Commun. 9 (2008) 2460.
[22] General procedure: a mixture of 9H-xanthen-9-ol (0.198 g, 1 mmol), nucleophilic reagents 2a–j (1 mmol), and Fe(HSO4)3. (0.035 g,
0.1 mmol) in ethanol (5 mL) was stirred at reflux for appropriate time according to Table 1. The progress of the reaction was monitored
by TLC. After the completion, the reaction mixture was filtered and the organic solvent was cooled and concentrated to afford crude product.
The crystalline pure product was obtained by further recrystallization from ethanol. Data for new compounds: N-(9H-Xanthen-9-yl)-1, 3-
thiazol-2-amine (3a): Yellow powder, yield: 0.249 g (89%). mp 188–189 8C, Anal. calcd. for C16H12N2OS (280.34): C, 68.55; H, 4.31; N,
9.99%. Found: C, 68.53; H, 4.29; N, 9.97%. 1H NMR (100 MHz, CDCl3): d 4.85 (br, s, 1H, NH), 5.45 (s, 1H, CH), 6.85 (d, 1H, CH), 7.24 (d,
1H, CH), 6.90–7.36 (m, 8H). IR (KBr, cmꢁ1) n: 3273 (NH), 3097, 1624, 1515, 1478, 1259, 761, 750. N-(9H-Xanthen-9-yl)-1, 3-benzothiazol-
2-amine (3b): Yellow powder, yield: 0.281 g (85%). mp 230–231 8C, Anal. calcd. for C20H14N2OS (330.40): C, 72.70; H, 4.27; N, 8.48%.
Found: C, 72.68; H, 4.25; N, 8.49%. 1H NMR (100 MHz, CDCl3): d5.81 (br, s, 1H, NH), 5.62 (s, 1H, CH), 7.15–7.76 (m, 12H). IR (KBr, cmꢁ1
)
n: 3162 (NH), 2976, 1594, 1568, 1536, 1481, 1255, 749. N-(9H-Xanthen-9-yl)-4H-1, 2, 4-triazol-4-amine (3c): White powder, yield: 0.251 g
(95%). mp 236–238 8C, Anal. calcd. for C15H12N4O (264.28): C, 68.17; H, 4.58; N, 21.20%. Found: C, 68.14; H, 4.60; N, 21.22%. 1H NMR
(100 MHz, CDCl3): d5.40 (d, 1H, NH), 5.55 (d, 1H, CH), 7.08–7.58 (m, 10H). IR (KBr, cmꢁ1) n: 3217 (NH), 3125, 1481, 1260, 1064, 775, 756,
632. 4-Amino-5-[2-(9H-xanthen-9-yl) hydrazinyl]-4H-1, 2, 4-triazole-3-thiol (3d): White powder, yield: 0.300 g (92%). mp 216–218 8C,
Anal. calcd. for C15H14N6OS (326.38): C, 55.20; H, 4.32; N, 25.75%. Found: C, 55.21; H, 4.30; N, 25.70%. 1H NMR (100 MHz, CDCl3): d 2.15
(br, s, 1H, NH), 4.25 (br, s, 1H, NH), 5.55 (s, 1H, CH), 5.77 (s, 2H, NH2), 7.05–7.45 (m, 8H), 13.26 (s, 1H, SH). IR (KBr, cmꢁ1) n: 3346, 3268
(NH), 3212 (NH2), 1645, 1601, 1481, 1260, 754. N-(9H-Xanthen-9-yl)-1H-tetrazol-5-amine (3e): White powder, yield: 0.255 g (96%). mp
235–236 8C, Anal. calcd. for C14H11N5O (265.27): C, 63.39; H, 4.18; N, 26.40%. Found: C, 63.36; H, 4.15; N, 26.36%. 1H NMR (100 MHz,
CDCl3): d 4.75 (d, 1H, NH), 4.65 (s, 1H, NH), 6.05 (d, 1H, CH), 6.87–7.58 (m, 8H). IR (KBr, cmꢁ1) n: 3396 (NH), 1576, 1483, 1258, 754. 5-
Methyl-4-(9H-xanthen-9-ylamino)-2, 4-dihydro-3H-1,2,4-triazole-3-thione (3f): White powder, yield: 0.285 g (92%). mp 201–203 8C, Anal.
calcd. for C16H14N4OS (310.37): C, 61.92; H, 4.55; N, 18.05%. Found: C, 61.90; H, 4.50; N, 18.01%. 1H NMR (100 MHz, CDCl3): d 1.29 (s,
3H, CH3), 5.27 (d, 1H, NH), 6.23 (d, 1H, CH), 7.11–7.65 (m, 8H), 10.90 (br, s, 1H, NH). IR (KBr, cmꢁ1) n: 3252 (NH), 3048, 1578, 1481, 1458,
1258, 756. 2-(9H-Xanthen-9-ylsulfanyl)-4, 5-dihydro-1H-imidazole (3g): White powder, yield: 0.240 g (85%). mp 178–179 8C, Anal. calcd.
for C16H14N2OS (282.36): C, 68.06; H, 5.00; N, 9.92%. Found: C, 68.10; H, 5.06; N, 9.90%. 1H NMR (100 MHz, CDCl3): d 3.15–3.36 (m, 2H,
CH2), 3.42–3.66 (m, 2H, CH2), 5.81 (br, s, 1H, NH), 7.10 (s, 1H, CH), 7.15–7.68 (m, 8H). IR (KBr, cmꢁ1) n: 3224 (NH), 2872, 1497, 1479,
1450, 1253, 759. 1-(4-Chlorophenyl)-2-(9H-xanthen-9-yl) hydrazine (3h): White powder, yield: 0.307 g (95%). mp 196–197 8C, Anal. calcd.
for C19H15ClN2O (322.79): C, 70.70; H, 4.68; N, 8.68%. Found: C, 70.67; H, 4.65; N, 8.65%. 1H NMR (100 MHz, CDCl3): d 5.05–5.21 (m, 2H,
NH-NH), 5.30 (d, 1H, CH), 7.04–7.72 (m, 12H). IR (KBr, cmꢁ1) n: 3256, 3157 (NH), 2966, 1622, 1566, 1263, 756. N-Phenyl-2-(9H-xanthen-
9-yl)hydrazinecarboxamide (3i): White powder, yield: 0.295 g (89%). mp 234–235 8C, Anal. calcd. for C20H17N3O2 (331.17): C, 72.49; H,
5.17; N, 12.68%. Found: C, 72.45; H, 5.15; N, 12.65%.1H NMR (100 MHz, DMSO): d 5.15 (s, 1H, CH), 5.45 (br, s, 1H, NH), 6.75 (br, s, 1H,
NH), 8.15 (br, s, 1H, NH), 7.10–7.70 (m, 13H). IR (KBr, cmꢁ1) n: 3334, 3249, 3240 (NH), 1658, 1537, 1481, 1261, 761. N4, N40-Di (9H-
xanthen-9-yl)-[1,10-biphenyl]-4, 4’-diamine (3j): White powder, yield: 0.517 g (95%). mp 267–268 8C, Anal. calcd. for C38H28N2O2 (544.64):
C, 83.80; H, 5.18; N, 5.14%. Found: C, 83.75; H, 5.15; N, 5.10%. 1H NMR (100 MHz, DMSO): d 3.65 (br, s, 2H, 2NH), 5.48 (s, 1H, CH), 6.75
(d, 4H, CH ortho), 6.91 (m, 20H). IR (KBr, cmꢁ1) n: 3468, 3374 (NH), 1625, 1498, 1477, 1445, 1249, 750.